Niki BioSolutions, Inc. Increase (Decrease) in Accounts Receivable
Niki BioSolutions, Inc. (NIKI) reported Increase (Decrease) in Accounts Receivable of -$41.35 thousand for the 12-month period ending 2024-12-31, per its S-4/A filed 2026-05-11.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2026-05-11
| Period end | Increase (Decrease) in Accounts Receivable 6 month | Increase (Decrease) in Accounts Receivable 12 month |
|---|---|---|
| 2024-12-31 | -$41.35K S-4/A · filed 2026-05-11 | |
| 2024-06-30 | -$18.27K 6-K · filed 2024-12-20 | |
| 2023-12-31 | -$126.72K S-4/A · filed 2026-05-11 | |
| 2023-06-30 | -$108.03K 6-K · filed 2024-12-20 | |
| 2022-12-31 | $95.70K 6-K · filed 2025-10-08 | |
| 2022-06-30 | -$6.91K 6-K · filed 2023-12-22 | |
| 2021-12-31 | $16.50K 20-F · filed 2024-04-30 | |
| 2021-06-30 | -$15.13K 6-K · filed 2022-09-30 | |
| 2020-12-31 | $21.68K 20-F · filed 2023-04-28 | |
| 2020-06-30 | $1.15K 6-K · filed 2021-09-15 | |
| 2019-12-31 | $37.72K 20-F/A · filed 2023-01-17 | |
| 2019-06-30 | $5.54K 6-K · filed 2020-09-02 | |
| 2018-12-31 | $2.83K 20-F · filed 2021-04-19 |